Twelve neutralizing monoclonal antibodies (MAbs) against the fish rhabdovirus, infectious haematopoietic necrosis virus (IHNV), were used to select 20 MAb escape mutants. The nucleotide sequence of the entire glycoprotein (G) gene was determined for six mutants representing differing cross-neutralization patterns and each had a single nucleotide change leading to a single amino acid substitution within one of three regions of the protein. These data were used to design nested PCR primers to amplify portions of the G gene of the 14 remaining mutants. When the PCR products from these mutants were sequenced, they also had single nucleotide substitutions coding for amino acid substitutions at the same, or nearby, locations. Of the 20 mutants for which all or part of the glycoprotein gene was sequenced, two MAbs selected mutants with substitutions at amino acids 230-231 (antigenic site I) and the remaining MAbs selected mutants with substitutions at amino acids 272-276 (antigenic site II). Two MAbs that selected mutants mapping to amino acids 272-276, selected other mutants that mapped to amino acids 78-81, raising the possibility that this portion of the N terminus of the protein was part of a discontinuous epitope defining antigenic site II. CLUSTAL alignment of the glycoproteins of rabies virus, vesicular stomatitis virus and IHNV revealed similarities in the location of the neutralizing epitopes and a high degree of conservation among cysteine residues, indicating that the glycoproteins of three different genera of animal rhabcloviruses may share a similar three-dimensional structure in spite of extensive sequence divergence.
Introduction
Infectious haematopoietic necrosis (IHN) is an acute viral disease of young salmon and trout (Wolf, 1988) . The disease is characterized by destruction of the haematopoietic tissues in the kidney and spleen of the fish resulting in mortality that may The nucleotide sequence of the glycoprotein gene of the WRAC isolate of IHNV reported in this paper has been deposited with GenBank under accession number L40882. approach I00 % among populations of juvenile rainbow trout (Oncorhynchus mykiss), sockeye salmon (O. nerka) and chinook salmon (O. tshawytscha). Originally enzootic in the western portion of North America, the causative agent, infectious haematopoietic necrosis virus (IHNV), has been spread to Asia and to Europe by the shipment of infected fish or eggs. At present, no chemotherapeutic agents or licensed vaccines are available and control of IHN relies upon avoidance of exposure to the virus and destruction of infected fish (Winton, 1991) .
Proposed as a member of a novel genus of the Rhabdoviridae (Morzunov et al., 1995) , IHNV has an unsegmented, negativesense, single-stranded RNA genome of 11131 nucleotides encoding six proteins: a nucleoprotein (N), a phosphoprotein (P or M1), a matrix protein (M or M2), a glycoprotein (G), a non-virion protein (NV), and a polymerase (L). The nudeotide sequence of the glycoprotein gene of IHNV was first determined by Koener et al. (1987) and translation of the ORF predicts that the complete glycoprotein is composed of 508 amino acids. The computer algorithm of Von Heijne (I986) identifies a 20 amino acid signal sequence at the amino terminus of the protein that is probably cleaved to produce a mature glycoprotein of 488 amino acids.
The IHNV glycoprotein has been shown to be capable of eliciting neutralizing antibodies (Engelking & Leong, 1989) and has been the focus of research to develop vaccines for control of IHN in hatchery fish (Winton, 1991) . An early map of the antigenic sites on the IHNV glycoprotein was provided by Xu et al. (1991) who expressed different regions of the G gene using Escherichia coil and probed Western blots of the fusion proteins with neutralizing and non-neutralizing monoclonal antibodies (MAbs).
Both linear and discontinuous neutralizing epitopes on the glycoproteins of members of two other genera of animal rhabdoviruses, rabies virus (Self et al., 1985; Prehaud et al., 1988; Dietzschold et al., 1990; Benmansour ef aI., 1991) and vesicular stomatitis virus (Vandepol et al., 1986; Luo et al., 1988) , have been mapped by sequence analysis of the glycoprotein gene of MAb escape mutants. The vast majority of rabies virus escape mutants have single amino acid substitutions within one of two, independent, major antigenic sites (Benmansour et al., 1991) . Antigenic site II is a discontinuous site located at amino acids 34-42 and 198-203 , while antigenic site III is located between amino acids 330--338. Like rabies virus, the majority of the neutralizing epitopes of the New Jersey serotype of vesicular stomatitis virus (VSV) map to the central portion of the protein (Luo ef al., 1988) .
In this study, we used a panel of neutralizing MAbs against a reference strain of IHNV (Huang et al., 1994) to select a series of escape mutants. We determined the sequence of the glycoprotein gene of the mutants in order to map the neutralizing epitopes of the IHNV glycoprotein in greater detail and to compare the location of the antigenic sites on this fish rhabdovirus with representatives of two mammalian genera of rhabdoviruses, rabies virus and VSV.
Methods
• Cells and virus. The epithelioma papulosum cyprini (EPC) cell line (Fijan et al., 1983) was grown in minimum essential medium (MEM; Gibco BRL) supplemented with 10% fetal bovine serum (Gibco BRL), 0"3 % tryptose phosphate broth (Difco), 100 IU/ml penicillin, 100 rtg/ml streptomycin, and 100 lag/ml gentarnicin (USB) at pH 7"5. The IHNV isolate used was the Western Regional Aquaculture Center (WRAC) reference strain (ATCC VR-1392; Morzunov et al., 1995) recovered in 1982 from rainbow trout at a commercial farm in the Hagerman Valley, Idaho, USA.
• Monoclonal antibodies. Huang et al. (1994) produced a panel of MAbs against the WRAC strain of IHNV by immunization of mice with gradient-purified whole virus. Thirty-one MAbs were selected solely on the basis of their virus neutralization ability. All 31 MAbs were shown by Western blot analysis to react with the native (non-denatured) form of the glycoprotein either before or after deglycosylation. However, only 9 of the 31 MAbs recognized the glycoprotein following denaturation with 2-mercaptoethanoI, suggesting that most of the neutralizing epitopes -t Titres are expressed as the highest dilution of the hybridoma culture supernatant completely neutralizing I x 104 p.f.u,/ml of IHNV. :1: lrnmunoblotting assay was performed using proteins separated by PAGE under non-denaturing conditions. § Binding ability of these MAbs was also maintained using proteins separated by PAGE under denaturing conditions. recognized by these MAbs were conformation-dependent (Huang et al., 1994) . Of the 31 MAbs, we chose 12 for use in this study ( Table 1) that had high levels of neutralizing activity and were of various isotypes. Eight of the MAbs were directed against conformation-dependent epitopes and four MAbs appeared to be directed against linear portions of the molecule.
• Selection of escape mutants. Selection of escape mutants from a stock preparation of wild-type IHNV was performed using a method similar to that described by Roberti et al. (1991) . Serial tenfold dilutions of the WRAC isolate were prepared and combined with an equal volume of hybridoma culture fluid containing one of the 12 neutralizing MAbs. The mixture was incubated for I h, then 0'1 ml of each combination was added to each of six wells of a 96-well plate containing monolayers of EPC cells. After 7 days incubation at 15 °C, culture fluid was removed from wells at the titration endpoint that showed CPE in the presence of MAb. The procedure was repeated until the titre of the virus preparation was the same in the presence or absence of the selecting MAb. Finally, the escape mutants were plaque-purified on EPC cell rnonolayers with an overlay containing the selecting MAb. After incubation, well-separated plaques were picked and the mutants were grown on EPC cells in 25 cm 2 flasks containing the selecting MAb. Each mutant was designated by the letter 'V' followed by the selecting MAb and a suffix indicating the number of the resistant done (e.g. VIH8 R1).
• Cross-neutralization test. Twenty escape mutants were tested for resistance to each of the twelve MAbs in a large cross-neutralization test. Each mutant was diluted to 1 x 104 p.f.u./ml in MEM and mixed with an equal volume of MAb. After I h incubation at 15 °C, the infectivity of the combination was determined by plaque assay using EPC Ping & Lemon (1992) . Based upon the results of the crossneutralization test, the 12 MAbs were placed into groups having similar patterns of reactivity with the 20 mutants.
• Isolation of mRNA and synthesis of cDNA. Two 75 cm 2 flasks of EPC cells were infected with wild-type [HNV or with one of the mutants. After I h incubation, actinomycin D was added at 0"5 itg/ml and the cultures were incubated at 15 °C for 24 h. Polyadenylated rnRNA was extracted from infected cell cultures using the FastTrack mRNA isolation kit ([nvitrogen) and reverse transcribed using a eDNA synthesis kit (Invitrogen).
• PCR and asymmetric PCR of the full-length glycoprotein gene. Primers were synthesized for PCR amplification of the entire glycoprotein gene using cDNA prepared from wild-type virus and from six of the escape mutants. Samples were amplified by 30 cycles of PCR and the products were purified by electrophoresis in 2-5 % tow-melting point (LMP) agarose (FMC BioProducts). The portion of the gel containing the DNA was excised, melted by heating at 65 °C for 15 min, and GELase (Epicentre Technologies) was used to digest the molten agarose. The gel-purified DNA was used as template for asymmetric PCR (A-PCR). The A-PCR reactions were identical to those used for standard PCR except that the primer ratios were 100:1 and the number of cycles was reduced to 25 (Gilbertson et al., 1991) . The DNA was purified using spin columns (Clontech). Both sense and antisense strands were amplified in separate reactions to provide templates for sequencing.
• Reverse transcription and nested PCR of portions of the glycoprotein gene. Two sets of nested primers were designed to directly amplify selected portions of the G gene of the remaining mutants. Culture fluid containing each mutant was diluted 1:100 with water, heated to 95 °C for 2 rain then cooled on crushed ice. The outer primer sets were used in RT-PCR and the thermocycler was programmed for reverse transcription for 15 rain at 50 °C, denaturation and RT inactivation for 2 rnin at 95 °C, followed by 25 cycles of regular PCR. The product was used as a template for a second amplification using the internal primer sets and 25 cycles of regular PCR. Product from the second PCR was gel-purified in 3 % LMP agarose in 1 x Tris-acetate/EDTA (TAE) buffer. The gel was stained with ethidium bromide, briefly visualized in UV light, and the DNA excised for further purification. The gel slice was heated to 70 °C for 2 rnin to melt the agarose and the PCR product concentrated using Wizard Magic Preps (Promega).
• DNA sequence analysis. The DNA sequence of the both the plus and minus strand products from A-PCR reactions was determined using the Sequenase sequencing kit Version 2.0 (USB) and the method of Sanger et al. (1977) . The PCR primers were used as the initial sequencing primers and other primers were synthesized as needed.
Both strands of the nested PCR products were sequenced using the internal PCR primers as sequencing primers and a fluorescent dye terminator cycle sequencing kit (Applied Biosystems). The PCR products selected for sequencing corresponded to the nucleotides coding for amino acids 60-145 and 205-335 of the IHNV glycoprotein. The sequence data were stored, aligned, and analysed using the PC/GENE (IntelliGenetics) software programs.
Results

Selection and characterization of escape mutants
Twelve neutralizing MAbs were used for selection of escape mutants. The neutralizing titres of the 12 hybridoma culture fluids were sufficiently high that mutants were readily obtained within three rounds of selection at which point the titres of the mutants were the same in the presence or absence of MAb. Following initial selection, the mutants were plaquepurified in the presence of MAb to ensure analysis of single clones and 20 plaques were selected from among the variants resistant to the 12 neutralizing MAbs.
The 20 escape mutants were tested for resistance to the 12 MAbs in a large cross-neutralization test (Table 2) . As expected, each mutant was fully resistant to the selecting MAb; however, the efficiency of neutralization by the other MAbs varied. Although not completely distinct, the 12 MAbs produced at least six patterns of reactivity indicating there were differences among the MAbs and in the neutralizing epitopes on the IHNV glycoprotein.
Mapping of mutations in the glycoprotein of escape mutants
To determine the locations of amino acid changes conferring resistance to neutralization, we determined the nucleotide sequence of the glycoprotein gene for the wild-type isolate and for a representative mutant from each of the six cross-neutralization groups. The entire G gene of each mutant (approximately 1"6 kb) was efficiently amplified by PCR from a cDNA template and single-stranded DNA was produced by A-PCR. Unambiguous consensus sequence was obtained from both strands and the data used to design sets of nested PCR primers to amplify regions of the G gene of the remaining mutants. Both strands of the inner PCR products were efficiently sequenced by automated methods using fluorescent terminators and a cyde sequencing kit.
Compared with the wild-type isolate (GenBank L40882), the G gene of each escape mutant contained only a single nucleotide substitution leading to a single amino acid substitution (Table 3) . Two MAbs, 1H8 and 5H2, selected mutants having substitutions at amino acids 230 and 231, respectively. This region of the IHNV glycoprotein was termed antigenic site I. The remaining MAbs selected escape mutants with substitutions at amino acids 272, 273, 275 or 276. This major antigenic region was termed antigenic site II. Two MAbs (5A6, 3B12) that selected mutants mapping to amino acids 272 and 275, also selected mutants that mapped near the N terminus of the protein at amino acids 78 and 81, respectively. The fact that the same MAb could select mutants mapping to widely spaced locations and that these mutants had similar patterns of reactivity in the cross-neutralization test suggested that some of the epitopes defining antigenic site II were discontinuous.
Discussion
We selected a series of escape mutants in order to map the neutralizing epitopes on the IHNV gIycoprotein and to compare their location with those of members of two other genera of animal rhabdoviruses. Cross-neutralization reactions between 20 mutants and 12 neutralizing MAbs produced six patterns of reactivity that were not completely distinct. However, when the sequence of the entire glycoprotein gene was determined for a mutant representing each of the patterns, the amino acid substitutions mapped to only three locations, indicating that part of the variation in the cross-neutralization reactions for these mutants was probably due to differences in the substituted amino acid or in the precise location of the substitution within the epitope. However, among mutants for which the entire gene was not sequenced, there were two cases (V2C5 R2 and V2H12 R1) where the patterns of neutralization resistance were different from other mutants having an identical amino acid substitution. Thus, for these two mutants, there may have been substitutions in other regions of the gene which produced subtle alterations in the conformation of the protein or access to the antibody binding site. Alternatively, some of the variation in our cross-neutralization reactions may have been due to pH-dependent shifts in the conformation of the IHNV glycoprotein, as described for rabies virus (Gaudin et al., 1993; Raux et al., I995) .
Because our MAbs were from hybridoma culture fluids having lower neutralizing titres than would be present in mouse ascites, our selection of escape mutants was not accomplished in a single step. Thus, we were not able to develop estimates of the mutation frequencies for the substitutions that we found. However, our hybridoma fluids had
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Rii ii:ii{ii ii{{i:i{{{{ii{ neutralizing abilities of greater than 10 a p.f.u./ml for the wildtype virus and within three rounds of selection, the titre of each mutant was the same in the presence or absence of MAb. When we sequenced either asymmetric or regular PCR products made from the G gene of the mutants, we found both methods produced templates that could be used directly for DNA sequencing without the need for cloning. This was advantageous as these PCR-based methods yield a consensus sequence that obviates the need to analyse a representative number of clones for each escape mutant (Benmansour et al., 1992; Sacramento et al., 1992) .
In mapping the neutralizing epitopes on the glycoprotein of IHNV, we assumed that the residues at which substitutions occurred were located within the actual epitope as has been demonstrated at the atomic level for the neuraminidase of influenza virus (Webster et al., 1987; Tulip et al., 1991) . Because MAbs 1H8 and 5H2 that mapped to amino acids 230--231 failed to react with reduced glycoproteins in immunoblots (Huang et al., 1994) , we believe the epitope defining antigenic site I is conformation-dependent; however, we cannot explain why MAb 1H8 selected mutants with substitutions at amino acid 230 that were also resistant to MAb 5H2, but MAb 5H2 selected mutants with substitutions at amino acid 231 that were fully neutralized by MAb 1H8. Perhaps the arginine residue at position 231 was not an essential amino acid within the portion of the epitope recognized by MAb 1H8. A restriction in the amino acid sequence changes that could be selected by a single MAb was demonstrated for a neutralizing epitope on the influenza virus N9 neuraminidase by Air et al. (I990) .
The majority of our MAbs (10 of I2) selected escape mutants with substitutions at amino acids 272-276 that defined at least a portion of antigenic site II. We believe this site contains a major neutralizing epitope of IHNV. The portion of the glycoprotein from amino acid 78-81 may be part of this discontinuous site because two of our MAbs selected mutants with substitutions at one or the other of these regions suggesting that they are either folded together on the surface of individual monomers, or reside at the interface of adjacent subunits of the glycoprotein trimer in a manner analogous to an epitope on the influenza A virus neuraminidase described by Saito et al. (I994) . In addition, we believe at least a portion of antigenic site II may contain a linear epitope because four of the MAbs that selected mutants mapping to amino acids 78-81 or 272-275 recognized the reduced G protein in immunoblots (Huang et al., 1994) . Thus, it may be possible to create a subunit vaccine for IHN based upon the amino acid sequence of these regions using methods similar to those described by Dietzschold et a] . (I990) for rabies virus. Oshima et al. (I995) used T1 ribonuclease fingerprinting to compare 26 isolates of IHNV from various locations in the western United States and estimated there was less than a 5 % difference among them at the genome level. When Nichol et al. (1995) compared the amino acid sequences of the glycoproteins of 12 diverse isolates of IHNV, they found a maximum pairwise divergence of only 3"7%. The region of the glycoprotein that included antigenic site I was highly conserved, but the amino acid sequence in the region of antigenic site II contained more substitutions than the average. Nevertheless, these data are generally encouraging for development of IHN vaccines because the variation in the glycoprotein of IHNV was substantially less than among isolates of VSV (Nichol et at., 1989) or rabies virus (Benmansour ef al., 1992) . Although many of the changes in field isolates of VSV occurred at, or near, antigenic sites (Nichol et al., 1989; Luo el al., 1990) , this was not true for rabies virus (Benmansour et al., 1992) . In addition, Domingo et al. (1993) have suggested that for RNA viruses, the role of immune selection in nature may be limited. Xu et al. (1991) mapped two non-neutralizing epitopes to the C-terminal half of the IHNV glycoprotein, and reported that this region, expressed in E. coli as a TrpE fusion protein, could induce a protective response in rainbow trout. Mourich & Leong (1991) used five overlapping synthetic peptides to study the region of the IHNV glycoprotein from amino acid 274-340. All peptides stimulated antibodies in mice that reacted with the IHNV glycoprotein in Western blots, but only peptide C (amino acid 321-340) stimulated antibody in rainbow trout. Although no evidence for neutralizing activity was presented, this region may contain a linear epitope that was not detected in our analysis or an epitope that does not give rise to neutralizing antibodies. While these methods of predicting epitopes have some significant limitations (LaFay et al., 1996; Laver et al., 1990) , it is important to note that the fish and the mouse immune systems did not recognize the same antigenic determinants, possibly confounding efforts to develop vaccines for fish based upon antigenic analyses using murine reagents. Nevertheless, Huang et al. (1994) showed that passive immunization of trout with MAbs 1H8 or 6A7 induced strong protection against waterborne challenge with IHNV indicating that if fish can produce antibodies of similar specificities, they should be protected.
The IHNV glycoprotein contains four potential glycosylation sites at amino acids 56, 400, 401 and 438. While it is not known which of the sites are actually used, the sites are not located near the epitopes we have identified. Huang et al. (I994) used endoglycosidase to remove carbohydrate moieties from the IHNV glycoprotein and reported that all the MAbs used in this study reacted with the deglycosylated protein, indicating that carbohydrate antigens were not involved in the epitopes we have identified.
Substitution of the arginine residue at position 333 of the rabies virus glycoprotein results in attenuation of virulence (Coulon et al., 1982 (Coulon et al., , 1983 Dietzschold et al., 1983; Self et al., 1985) . We did not find substitutions in the analogous region of the IHNV glycoprotein and, when small rainbow trout were challenged by waterborne exposure to escape mutants V3B12 R2, V1H8 R2, V5H2 RI, V5A6 R2, V6A7 R1 or VIEll R1 representing the different cross-neutralization reaction patterns, none of the mutants was significantly attenuated (data not shown). Roberti et al. (1991) used a neutralizing MAb to select IHNV escape mutants, one of which was highly attenuated for rainbow trout and able to confer significant protection against challenge with the wild-type strain. The virulent mutants showed typical tissue tropism, but had a single substitution at amino acid 276 that conferred resistance to neutralization while the attenuated mutant lacked the substitution at amino acid 276, but had a substitution at amino acid 78 that resulted in resistance to neutralization and a second substitution at amino acid 218 that resulted in attenuation of virulence and altered tissue tropism (Kim et al., 1994) . These results indicate that the MAb used by Roberti et al. (1991) was directed against an epitope in antigenic site II. While the precise three-dimensional structure of the IHNV glycoprotein cannot be determined without X-ray crystallography, a CLUSTAL alignment of the amino acid sequences of the VSV, rabies virus, and IHNV glycoproteins (Fig. I ) reveals some features that suggest a conservation of functional domains in spite of less than 5 % amino acid identity. Assuming that neutralizing epitopes are located on the surface of the native glycoprotein ), it appears from Fig. 1 that significant regions of the rhabdovirus glycoprotein must be buried in an internal portion of the molecule because the majority of the neutralizing epitopes of these viruses mapped to only four, relatively restricted, regions. Grigera et at. (1992) postulated the existence of a major loop structure within the first 193 N-terminal amino acids of the VSV glycoprotein. A buried loop would be consistent with the alignments shown where, with the exception of two mutations in the rabies virus glycoprotein each identified by a single MAb (Prehaud et al., 1988) , there is a notable absence of neutralizing epitopes within the region corresponding to VSV amino acids 75-200. A loop within the N-terminal half of the rabies virus and IHNV glycoproteins would likewise account for the discontinuous nature of antigenic site II of rabies virus which is composed of amino acids 34-42 and 198-200 (53--61 and 217-219 in Fig.  1 ) and of antigenic site II of IHNV, which we believe is composed of amino acids 78-81 and 272-276. Whirr et al. (1991) suggested the ectodomains of the VSV and rabies virus glycoproteins had similar three-dimensional structures and showed that the rabies virus glycoprotein, like that of VSV, was a trimer. Gaudin et al. (1992) used electron microscopy and sedimentation analysis to confirm the trimeric nature of the rabies virus glycoprotein and to reveal a 'head' and a' stalk' that provided a low-resolution model. Presumably, the IHNV glycoprotein could have a similar overall structure. Evidence that the glycoproteins of VSV, rabies virus, and IHNV have similar three-dimensional structures is provided by the conservation of an unusual number of cysteine residues (Fig. 1) which were shown by Grigera et al. (1992) to be critical for maintaining the disulphide-bonded secondary structure and discontinuous epitopes of VSV. Ultimately, a more detailed knowledge of the IHNV glycoprotein will be required to advance our understanding of viral pathogenesis and the fish immune system in order to design better vaccines for protecting fish against this important disease.
